1-20 of 112
Brian G Till
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial

Timothy S. Fenske, Xin Victoria Wang, Brian G. Till, Kristie A. Blum, Matthew Lunning, Hillard M. Lazarus, Paul A.S. Fishkin, Lale Kostakoglu Shields, David W. Scott, Ann S. LaCasce, Patrick B. Johnston, Amanda F. Cashen, Leslie L. Popplewell, Robert M. Dean, Nausheen Ahmed, Nirav N. Shah, Nina D. Wagner-Johnston, Boyu Hu, Bhagirathbhai R. Dholaria, Richard F. Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl
Journal: Blood
Blood (2024) 144 (Supplement 2): LBA-6.
https://doi.org/10.1182/blood-2024-212973
Published: 2024
Journal Articles

A Pilot Trial of Low Dose-Mosunetuzumab for Low-Tumor Burden Indolent B-Cell Lymphoma: Trial in Progress

Carrie I Ho, Mengyang Di, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Mazyar Shadman, Stephen D. Smith, Brian G. Till, Paul S Martin, Chaitra S. Ujjani, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 1661.2.
https://doi.org/10.1182/blood-2024-204154
Published: 2024
Journal Articles

Acalabrutinib and Venetoclax (AV) Combination for 2 Years for Patients with Previously Treated CLL/SLL - the Avenue-2 Trial

Jennifer J. Huang, Laura Samples, Margie Fredericks, Stephanie Louie, Ramya Pulluru, Christine Crider, Mehrdad Shakib-Azar, Neena Kennedy, Vikram Raghunathan, Christina Poh, Mengyang Di, Stephen D. Smith, Brian G. Till, Ajay K. Gopal, Chaitra S. Ujjani, Ryan C. Lynch, Mazyar Shadman
Journal: Blood
Blood (2024) 144 (Supplement 1): 4634.2.
https://doi.org/10.1182/blood-2024-204491
Published: 2024
Journal Articles

Pralatrexate Is Effective in Cytotoxic Cutaneous T-Cell Lymphomas

Christina Poh, Jenna M. Voutsinas, Ivan Huang, Edus H. Warren, Caitlin A. Crimp, Mazyar Shadman, Ryan C. Lynch, Brian G. Till, Chaitra S. Ujjani, Mengyang Di, Vikram Raghunathan, Stephen D. Smith, Qian Vicky Wu, Michi M. Shinohara, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 1684.
https://doi.org/10.1182/blood-2024-194018
Published: 2024
Journal Articles

Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin (P-GVD) for Classical Hodgkin Lymphoma (CHL) in the Real-World Setting

Grace T. Baek, Gaurav Varma, Samuel Yamshon, Herman van Besien, Nancy L. Bartlett, Marcus P. Watkins, Harsh R. Shah, Kelsey Baron, Reid W. Merryman, Ayo S Falade, Jakub Svoboda, Sara Prischak, Christopher R D'Angelo, Joe D. Lukowski, Ranjana H. Advani, Austin H. Yeung, Maya C. Rosenberg, Jenna M. Voutsinas, Mengyang Di, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Mazyar Shadman, Stephen D. Smith, Brian G. Till, Chaitra S. Ujjani, Catherine S. Diefenbach, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 4431.
https://doi.org/10.1182/blood-2024-200719
Published: 2024
Journal Articles

Autoimmune Outcomes in Patients with Concurrent Autoimmune Disease Receiving CD19 CAR T-Cell Therapy for Lymphoma

Jennifer J. Huang, Namrata Singh, Mazyar Shadman, Ryan S. Basom, Andrea Kalus, Andrew J Portuguese, Emily C Liang, Natalie Wuliji, Alexandre V. Vinaud Hirayama, Aude G Chapuis, Folashade Otegbeye, Filippo Milano, Ryan D. Cassaday, Ajay K. Gopal, Brian G. Till, Edus H. Warren, Jordan Gauthier, Lawrence Fong, David G. Maloney
Journal: Blood
Blood (2024) 144 (Supplement 1): 7132.
https://doi.org/10.1182/blood-2024-201809
Published: 2024
Journal Articles

Real-World Blood Counts in Patients Treated with Venetoclax for Relapsed or Refractory CLL/SLL

Laura Samples, Sirin Khajaviyan, Sara Keshmiri, Ryan S. Basom, Ryan C Lynch, Vikram Raghunathan, Mengyang Di, Mehrdad Shakib-Azar, Christine Crider, Margie Fredericks, Christina Poh, Stephanie Louie, Stephen D. Smith, Brian G. Till, Ajay K. Gopal, Chaitra S. Ujjani, Mazyar Shadman
Journal: Blood
Blood (2024) 144 (Supplement 1): 6785.
https://doi.org/10.1182/blood-2024-211971
Published: 2024
Journal Articles

Dose-Dense Brentuximab Vedotin Plus Ifosfamide, Carboplatin, and Etoposide (ICE) in Second Line Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma: 5-Year Long Term Follow up

Ryan C. Lynch, Ryan D. Cassaday, Stephen D. Smith, Andrew J. Cowan, Edus H. Warren, Mazyar Shadman, Brian G. Till, Chaitra S. Ujjani, Karolyn Morris, Heather Rasmussen, Jenna M. Voutsinas, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 3043.
https://doi.org/10.1182/blood-2024-206047
Published: 2024
Journal Articles

Quality of Life during Survivorship Following Autologous Stem Cell Transplant for Mantle Cell Lymphoma

Mengyang Di, Carrie I Ho, Stephen D. Smith, Mazyar Shadman, Chaitra S. Ujjani, Ryan C. Lynch, Christina Poh, Vikram Raghunathan, Brian G. Till, Edus H. Warren, Ajay K. Gopal, Stephanie J. Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 5116.
https://doi.org/10.1182/blood-2024-201827
Published: 2024
Journal Articles

Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma: A Single-Center Retrospective Analysis

Carrie I Ho, Neena Kennedy, Mengyang Di, Ajay K. Gopal, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Heather Rasmussen, Mazyar Shadman, Brian G. Till, Chaitra S. Ujjani, Stephen D. Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 783.
https://doi.org/10.1182/blood-2024-208269
Published: 2024
Journal Articles

Impact of Immunophenotype on Clinical Disease Characteristics and Outcomes in T-Cell Prolymphocytic Leukemia

Christina Poh, Xueyan Chen, Jenna M. Voutsinas, Edus H. Warren, Mazyar Shadman, Ryan C. Lynch, Brian G. Till, Chaitra S. Ujjani, Mengyang Di, Vikram Raghunathan, Stephen D. Smith, Qian Vicky Wu, Sindhu Cherian, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 3069.
https://doi.org/10.1182/blood-2024-205892
Published: 2024
Journal Articles

EO2463 Peptide Immunotherapy in Patients with Newly Diagnosed Asymptomatic Follicular Lymphoma Results in Monotherapy Objective Clinical Responses Linked with Anti-Peptide Specific CD8 Memory T Cell Responses: The EONHL1-20/Sidney Study

Jose C. Villasboas Bisneto, Stephen D. Smith, Danielle S Wallace, Jean Pierre Marolleau, Carlos Grande Garcia, Reid W. Merryman, Francesc Bosch, Luca Arcaini, Antonio Pinto, Norma C. Gutierrez, Brian G. Till, Pierre Morel, Rocío Figueroa Mora, Cristina García, Sara Rattotti, Lucie Aubergeon, Laurent Chêne, Jan Fagerberg, Pier Luigi Zinzani, Philippe Armand, Jonathan W. Friedberg, Stephen M. Ansell
Journal: Blood
Blood (2024) 144 (Supplement 1): 4395.
https://doi.org/10.1182/blood-2024-201269
Published: 2024
Journal Articles

EO2463 Peptide Immunotherapy in Patients with Indolent NHL: A Phase 1 Exploration of a Response Biomarker for EO2463 Monotherapy and EO2463 in Combination with Lenalidomide/Rituximab

Jose C. Villasboas Bisneto, Danielle S Wallace, Francesc Bosch, Carlos Grande Garcia, Stephen D. Smith, Antonio Pinto, Reid W. Merryman, Norma C. Gutierrez, Jean Pierre Marolleau, Luca Arcaini, Cristina García, Rocío Figueroa Mora, Brian G. Till, Rosaria De Filippi, Sara Rattotti, Lucie Aubergeon, Laurent Chêne, Jan Fagerberg, Pier Luigi Zinzani, Philippe Armand, Jonathan W. Friedberg, Stephen M. Ansell
Journal: Blood
Blood (2024) 144 (Supplement 1): 1616.
https://doi.org/10.1182/blood-2024-204593
Published: 2024
Journal Articles

Gamma Secretase Inhibition May Mitigate the Impact of Low BCMA Target Density in Relapsed/Refractory Multiple Myeloma: Results from a Comparative Analysis of Two Phase 1 Clinical Trials

Andrew J Portuguese, Sherilyn A. Tuazon, Margot J. Pont, Gabriel Cole, Blythe Duke Sather, Xiaoling Song, Brent L. Wood, Michelle Lee Blake, Melissa Works, Mazyar Shadman, Qian Vicky Wu, Jenna M. Voutsinas, Ted Gooley, Cameron J. Turtle, Brian G. Till, David G. Coffey, David G. Maloney, Edward Libby, Aude G Chapuis, Filippo Milano, Stanley R. Riddell, Andrew J. Cowan, Damian J. Green
Journal: Blood
Blood (2024) 144 (Supplement 1): 4832.
https://doi.org/10.1182/blood-2024-205942
Published: 2024
Journal Articles

Potential Delayed Immune-Related Adverse Events in Patients Treated with Frontline Pembrolizumab + AVD for Classic Hodgkin Lymphoma

Thomas M Kuczmarski, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Brian G. Till, Vikram Raghunathan, Yolanda D Tseng, Hongyan Du, Jacquelin Vandermeer, Alyssa Kelly, Heather Rasmussen, Jenna M. Voutsinas, Ajay K. Gopal, Ryan C Lynch
Journal: Blood
Blood (2024) 144 (Supplement 1): 1667.
https://doi.org/10.1182/blood-2024-208412
Published: 2024
Journal Articles

Low Rates of Febrile Neutropenia Despite Frequent Grade 4 Neutropenia in Patients Treated with Pembrolizumab + AVD in Untreated Classic Hodgkin Lymphoma

Thomas M Kuczmarski, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Brian G. Till, Vikram Raghunathan, Yolanda D Tseng, Hongyan Du, Jacquelin Vandermeer, Alyssa Kelly, Heather Rasmussen, Jenna M. Voutsinas, Ajay K. Gopal, Ryan C Lynch
Journal: Blood
Blood (2024) 144 (Supplement 1): 1666.
https://doi.org/10.1182/blood-2024-206601
Published: 2024
Journal Articles

High Rates of Undetectable MRD By Phased-Seq on Interim and End of Treatment Timepoints in Untreated Advanced Stage Chl Treated with Pembrolizumab + AVD

Ryan C Lynch, Stefan K. Alig, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Brian G. Till, Vikram Raghunathan, Yolanda D Tseng, Susan Ottemiller, Bonnie Joy, Melissa Mary Fessel, Hongyan Du, Jacquelin Vandermeer, Alyssa Kelly, Heather Rasmussen, Jenna M. Voutsinas, Ash A. Alizadeh, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 3051.
https://doi.org/10.1182/blood-2024-206512
Published: 2024
Journal Articles

HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation

Clinical Trials & Observations
Elizabeth F. Krakow, Michelle Brault, Corinne Summers, Tanya M. Cunningham, Melinda A. Biernacki, R. Graeme Black, Kyle B. Woodward, Nicole Vartanian, Sami B. Kanaan, Albert C. Yeh, Robson G. Dossa, Merav Bar, Ryan D. Cassaday, Ann Dahlberg, Brian G. Till, Andrew E. Denker, Cecilia C. S. Yeung, Ted A. Gooley, David G. Maloney, Stanley R. Riddell, Philip D. Greenberg, Aude G. Chapuis, Evan W. Newell, Scott N. Furlan, Marie Bleakley
Journal: Blood
Blood (2024) 144 (10): 1069–1082.
https://doi.org/10.1182/blood.2024024105
Published: 2024
Includes: Supplemental data
Journal Articles

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

Clinical Trials & Observations
Mitchell R. Smith, Opeyemi A. Jegede, Peter Martin, Brian G. Till, Samir S. Parekh, David T. Yang, Eric D. Hsi, Thomas Witzig, Sandeep Dave, David Scott, Curtis Hanson, Lale Kostakoglu Shields, Nizar Abdel-Samad, Carla Casulo, Nancy L. Bartlett, Paolo F. Caimi, Tareq Al Baghdadi, Kristie A. Blum, Mark D. Romer, David J. Inwards, Rachel E. Lerner, Lynne I. Wagner, Richard F. Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl
Journal: Blood
Blood (2024) 144 (10): 1083–1092.
https://doi.org/10.1182/blood.2024023962
Published: 2024
Includes: Supplemental data
Journal Articles

Durable Remissions in Advanced Stage and Molecularly High Risk Untreated Classic Hodgkin Lymphoma with Pembrolizumab + AVD

Ryan C Lynch, Stefan K. Alig, Chaitra S Ujjani, Christina Poh, Edus H Warren, Stephen D Smith, Mazyar Shadman, Brian G Till, Vikram Raghunathan, Yolanda D Tseng, Susan Ottemiller, Bonnie Joy, Melissa Mary Fessel, Hongyan Du, Jacquelin Vandermeer, Alyssa Kelly, Heather Rasmussen, Jenna M Voutsinas, Qian Wu, Ash A. Alizadeh, Ajay K Gopal
Journal: Blood
Blood (2023) 142 (Supplement 1): 4429.
https://doi.org/10.1182/blood-2023-179547
Published: 2023